Insider Transactions in Q2 2022 at Athenex, Inc. (ATNX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
23,356
+0.68%
|
$0
$0.49 P/Share
|
|
Jun 17
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,832
+9.08%
|
$0
$0.49 P/Share
|
|
Jun 17
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,025
+14.31%
|
$0
$0.49 P/Share
|
|
Jun 03
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
23,095
+0.68%
|
$0
$0.49 P/Share
|
|
Jun 03
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,927
+4.25%
|
$0
$0.49 P/Share
|
|
Jun 03
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,013
+16.54%
|
$0
$0.49 P/Share
|
|
May 20
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
23,583
+0.7%
|
$0
$0.48 P/Share
|
|
May 20
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,137
+4.53%
|
$0
$0.48 P/Share
|
|
May 20
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,034
+20.15%
|
$0
$0.48 P/Share
|
|
May 06
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
23,516
+0.7%
|
$0
$0.05 P/Share
|
|
May 06
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,107
+4.73%
|
$0
$0.48 P/Share
|
|
May 06
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,031
+25.18%
|
$0
$0.48 P/Share
|
|
Apr 22
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
18,578
+0.56%
|
$0
$0.61 P/Share
|
|
Apr 22
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,986
+3.96%
|
$0
$0.61 P/Share
|
|
Apr 22
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
815
+28.62%
|
$0
$0.61 P/Share
|
|
Apr 08
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
665
+35.32%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
15,160
+0.46%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
Stephanie A Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,316
+19.36%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
Manson Fok Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,973
+0.49%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,516
+3.39%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
Robert J. Spiegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,989
+50.0%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
Benson Kwan Hung Tsang Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,292
+37.68%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
John Vierling Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,303
+42.89%
|
$0
$0.75 P/Share
|
|
Apr 08
2022
|
Jinn Wu Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,303
+2.43%
|
$0
$0.75 P/Share
|